MICHELLE INIGUEZ: Open Payments
NPI 1578103859 · GREENVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$695 in 34 payments from 13 companies in 2025. Trend: 2023 $1,030 · 2024 $811 · 2025 $695
Food & beverage: $587Education: $79Travel & lodging: $28
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 10 | $159 |
| AstraZeneca Pharmaceuticals LP | 4 | $92 |
| SANOFI-AVENTIS U.S. LLC | 1 | $79 |
| Viatris Specialty LLC | 3 | $73 |
| GENZYME CORPORATION | 3 | $68 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
| Grifols USA, LLC | 2 | $39 |
| Inspire Medical Systems, Inc. | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Baxter Healthcare | 1 | $22 |
Products named: DUPIXENT, NUCALA, TRELEGY ELLIPTA, YUPELRI, TEZSPIRE, Prolastin-C Liquid, INSPIRE, FASENRA.
Industry payments across TX — which companies pay providers there.
